vs

Side-by-side financial comparison of RAPID MICRO BIOSYSTEMS, INC. (RPID) and Waters Corporation (WAT). Click either name above to swap in a different company.

Waters Corporation is the larger business by last-quarter revenue ($932.4M vs $11.3M, roughly 82.6× RAPID MICRO BIOSYSTEMS, INC.). Waters Corporation runs the higher net margin — 24.2% vs -110.8%, a 134.9% gap on every dollar of revenue. On growth, RAPID MICRO BIOSYSTEMS, INC. posted the faster year-over-year revenue change (37.3% vs 6.8%). Over the past eight quarters, RAPID MICRO BIOSYSTEMS, INC.'s revenue compounded faster (41.8% CAGR vs 21.0%).

Rapid Micro Biosystems, Inc. develops and manufactures automated microbial detection and quality control solutions for the life sciences industry. Its core products serve biopharmaceutical manufacturers, contract development and manufacturing organizations, operating across key global markets including North America, Europe and Asia-Pacific, helping clients cut testing timelines and improve operational efficiency.

Waters Corporation is an American company headquartered in Milford, Massachusetts that provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life sciences, materials, and food industries.

RPID vs WAT — Head-to-Head

Bigger by revenue
WAT
WAT
82.6× larger
WAT
$932.4M
$11.3M
RPID
Growing faster (revenue YoY)
RPID
RPID
+30.4% gap
RPID
37.3%
6.8%
WAT
Higher net margin
WAT
WAT
134.9% more per $
WAT
24.2%
-110.8%
RPID
Faster 2-yr revenue CAGR
RPID
RPID
Annualised
RPID
41.8%
21.0%
WAT

Income Statement — Q4 2025 vs Q4 2025

Metric
RPID
RPID
WAT
WAT
Revenue
$11.3M
$932.4M
Net Profit
$-12.5M
$225.2M
Gross Margin
61.1%
Operating Margin
-108.2%
29.0%
Net Margin
-110.8%
24.2%
Revenue YoY
37.3%
6.8%
Net Profit YoY
-29.3%
-2.7%
EPS (diluted)
$-0.26
$3.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RPID
RPID
WAT
WAT
Q4 25
$11.3M
$932.4M
Q3 25
$7.8M
$799.9M
Q2 25
$7.3M
$771.3M
Q1 25
$7.2M
$661.7M
Q4 24
$8.2M
$872.7M
Q3 24
$7.6M
$740.3M
Q2 24
$6.6M
$708.5M
Q1 24
$5.6M
$636.8M
Net Profit
RPID
RPID
WAT
WAT
Q4 25
$-12.5M
$225.2M
Q3 25
$-11.5M
$148.9M
Q2 25
$-11.9M
$147.1M
Q1 25
$-11.3M
$121.4M
Q4 24
$-9.7M
$231.4M
Q3 24
$-11.3M
$161.5M
Q2 24
$-12.6M
$142.7M
Q1 24
$-13.3M
$102.2M
Gross Margin
RPID
RPID
WAT
WAT
Q4 25
61.1%
Q3 25
59.0%
Q2 25
58.3%
Q1 25
58.2%
Q4 24
60.1%
Q3 24
59.3%
Q2 24
59.3%
Q1 24
58.9%
Operating Margin
RPID
RPID
WAT
WAT
Q4 25
-108.2%
29.0%
Q3 25
-145.1%
24.0%
Q2 25
-167.3%
24.4%
Q1 25
-161.8%
22.9%
Q4 24
-124.5%
33.5%
Q3 24
-158.3%
28.5%
Q2 24
-202.1%
26.7%
Q1 24
-254.4%
21.0%
Net Margin
RPID
RPID
WAT
WAT
Q4 25
-110.8%
24.2%
Q3 25
-146.8%
18.6%
Q2 25
-163.3%
19.1%
Q1 25
-156.3%
18.3%
Q4 24
-117.6%
26.5%
Q3 24
-148.9%
21.8%
Q2 24
-190.1%
20.1%
Q1 24
-237.4%
16.0%
EPS (diluted)
RPID
RPID
WAT
WAT
Q4 25
$-0.26
$3.76
Q3 25
$-0.26
$2.50
Q2 25
$-0.27
$2.47
Q1 25
$-0.26
$2.03
Q4 24
$-0.22
$3.88
Q3 24
$-0.26
$2.71
Q2 24
$-0.29
$2.40
Q1 24
$-0.31
$1.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RPID
RPID
WAT
WAT
Cash + ST InvestmentsLiquidity on hand
$20.0M
$587.8M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$33.2M
$2.6B
Total Assets
$74.9M
$5.1B
Debt / EquityLower = less leverage
0.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RPID
RPID
WAT
WAT
Q4 25
$20.0M
$587.8M
Q3 25
$18.9M
$459.1M
Q2 25
$18.3M
$367.2M
Q1 25
$18.9M
$382.9M
Q4 24
$16.9M
$325.4M
Q3 24
$22.0M
$331.5M
Q2 24
$37.1M
$327.4M
Q1 24
$22.4M
$338.2M
Total Debt
RPID
RPID
WAT
WAT
Q4 25
$1.4B
Q3 25
Q2 25
Q1 25
Q4 24
$1.6B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
RPID
RPID
WAT
WAT
Q4 25
$33.2M
$2.6B
Q3 25
$44.3M
$2.3B
Q2 25
$54.5M
$2.2B
Q1 25
$65.5M
$2.0B
Q4 24
$75.4M
$1.8B
Q3 24
$84.4M
$1.6B
Q2 24
$94.6M
$1.4B
Q1 24
$105.9M
$1.3B
Total Assets
RPID
RPID
WAT
WAT
Q4 25
$74.9M
$5.1B
Q3 25
$84.4M
$4.9B
Q2 25
$75.6M
$4.7B
Q1 25
$85.4M
$4.6B
Q4 24
$98.2M
$4.6B
Q3 24
$105.8M
$4.5B
Q2 24
$117.1M
$4.4B
Q1 24
$127.7M
$4.5B
Debt / Equity
RPID
RPID
WAT
WAT
Q4 25
0.55×
Q3 25
Q2 25
Q1 25
Q4 24
0.89×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RPID
RPID
WAT
WAT
Operating Cash FlowLast quarter
$-3.2M
$164.6M
Free Cash FlowOCF − Capex
$-3.3M
FCF MarginFCF / Revenue
-29.6%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
0.73×
TTM Free Cash FlowTrailing 4 quarters
$-31.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RPID
RPID
WAT
WAT
Q4 25
$-3.2M
$164.6M
Q3 25
$-9.1M
$187.3M
Q2 25
$-9.7M
$41.1M
Q1 25
$-9.1M
$259.6M
Q4 24
$-9.9M
$240.1M
Q3 24
$-8.6M
$204.6M
Q2 24
$-10.1M
$54.5M
Q1 24
$-15.5M
$262.9M
Free Cash Flow
RPID
RPID
WAT
WAT
Q4 25
$-3.3M
Q3 25
$-9.1M
Q2 25
$-10.1M
Q1 25
$-9.4M
Q4 24
$-10.0M
Q3 24
$-8.8M
Q2 24
$-10.6M
Q1 24
$-16.1M
FCF Margin
RPID
RPID
WAT
WAT
Q4 25
-29.6%
Q3 25
-116.4%
Q2 25
-138.6%
Q1 25
-130.2%
Q4 24
-121.8%
Q3 24
-116.0%
Q2 24
-159.8%
Q1 24
-287.1%
Capex Intensity
RPID
RPID
WAT
WAT
Q4 25
0.8%
Q3 25
0.9%
Q2 25
5.0%
Q1 25
4.4%
Q4 24
1.2%
Q3 24
2.9%
Q2 24
6.9%
Q1 24
10.4%
Cash Conversion
RPID
RPID
WAT
WAT
Q4 25
0.73×
Q3 25
1.26×
Q2 25
0.28×
Q1 25
2.14×
Q4 24
1.04×
Q3 24
1.27×
Q2 24
0.38×
Q1 24
2.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RPID
RPID

Products$9.3M83%
Services$2.0M17%

WAT
WAT

Segment breakdown not available.

Related Comparisons